Sign in

CIK 0001710340

  • Non-accelerated filer
  • Smaller reporting company

Eton Pharmaceuticals, Inc.

Sign in to watch
Ticker
ETON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
371858472
Phone
+1 847-787-7361
Business address
21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
  1. 4 Open-market sale Chief Financial Officer sold 41,713 shares at an average $16.15 ($673,714)
  2. 4 Open-market sale Chief Business Officer sold 34,000 shares at an average $14.83 ($504,318)
  3. 4 Open-market buy 10% owner bought 7,930 shares at $15.82 ($125,484)
  4. 4 Open-market sale President & CEO sold 210,000 shares at an average $17.11 ($3,592,611)
  5. 4 Derivatives Options or other derivatives
  6. 4 Exercise or conversion Director acquired 102,400 shares (option exercise)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy 10% owner bought 10,000 shares at $7.98 ($79,814)
  15. 4 Open-market buy 10% owner bought 62,070 shares at an average $6.99 ($434,137)
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy 10% owner bought 107,500 shares at an average $4.70 ($504,875)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 7 · 133 filings